Neurocrine Biosciences

AbbVie

Gilead Sciences

BioMarin Pharmaceutical

United Therapeutics

Sarepta Therapeutics

Natera

Amgen

Incyte

Alnylam Pharmaceuticals

SPDR S&P Biotech ETF

XBI tracks an equal-weighted index of US biotechnology stocks.

ARK Genomic Revolution Multi-Sector ETF

Invesco Dynamic Biotechnology & Genome ETF

ALPS Medical Breakthroughs ETF

Pfizer struck a deal to acquire the cancer drugmaker Array Biopharma for $11 billion in an all-cash consideration.

Pfizer-Array Biopharma Deal Bump Up Biotech ETFs

iShares Nasdaq Biotechnology ETF

Pfizer's deal to buy Array BioPharma for $10.6 billion has ignited biotech stocks. There are ways to get in on the rally using exchange-traded funds.

Biotech ETFs are breaking out—here are 3 ways to play the space

Institutional players are abandoning biotech funds at a rapid pace, raising the odds that the sector will enter a bear market.

Biotech Sector Could Enter Bear Market

iShares U.S. Medical Devices ETF

Illumina

Intuitive Surgical

Johnson & Johnson

Teladoc

Vertex Pharmaceuticals

Health Care Select Sector SPDR Fund

The global demand for healthcare products and services will keep growing significantly. Here's your complete guide to finding the best healthcare stocks and ETFs.

Everything You Need to Know About Investing in Healthcare

VanEck Vectors Biotech ETF

Biogen

Bristol-Myers

Celgene

First Trust NYSE Arca Biotechnology Index Fund

Direxion Daily S&P Biotech Bull 3X Shares

Regeneron Pharmaceuticals

When the stock market is hitting record highs, it’s important to remember that it’s really a market of stocks rather than a stock market. Not all companies are created equal. Nor are all sectors.

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

First Trust Materials AlphaDEX Fund

Invesco DWA Technology Momentum ETF

PowerShares Russell Midcap Pure Growth Portfolio

Vanguard Russell 2000 Growth 

High-beta ETFs & stocks seek to capitalize on continued growth with market-beating returns.

S&P 500 Hit New Records: Buy These High-Beta ETFs

Virtus LifeSci Biotech Products ETF

Principal Healthcare Innovators Index ETF

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

Biotechnology Market on a Tear: 5 ETFs in Spotlight

Xtrackers Harvest CSI 300 China A-Shares ETF

Xtrackers MSCI China A Inclusion Equity ETF

KraneShares Bosera MSCI China A Share ETF

Invesco Golden Dragon China ETF

SPDR S&P Software & Services ETF

We are presenting a bunch of top performing ETFs of the first quarter with a solid Zacks ETF Rank #1 or 2 which are expected to outperform in the quarter ahead.

A Spread of Top-Ranked ETFs That Crushed the Market in Q1

News for SPDR S&P Biotech ETF ETF (XBI)